Cargando…
Adjuvant Vaccination with Allogenic Dendritic Cells Significantly Prolongs Overall Survival in High-Grade Gliomas: Results of a Phase II Trial
SIMPLE SUMMARY: Among all intracranial tumors, 31.5% are malignant, and among those, glioblastomas account for 47%. Recently, our group reported the case of a patient with glioblastoma who underwent vaccination based on dendritic cells and experienced near-complete tumor remission. Here we report th...
Autores principales: | Lepski, Guilherme, Bergami-Santos, Patricia C., Pinho, Mariana P., Chauca-Torres, Nadia E., Evangelista, Gabriela C. M., Teixeira, Sarah F., Flatow, Elizabeth, de Oliveira, Jaqueline V., Fogolin, Carla, Peres, Nataly, Arévalo, Analía, Alves, Venâncio A. F., Barbuto, José A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953909/ https://www.ncbi.nlm.nih.gov/pubmed/36831580 http://dx.doi.org/10.3390/cancers15041239 |
Ejemplares similares
-
Near-Complete Remission of Glioblastoma in a Patient Treated with an Allogenic Dendritic Cell-Based Vaccine: The Role of Tumor-Specific CD4+T-Cell Cytokine Secretion Pattern in Predicting Response and Recurrence
por: Pinho, Mariana P., et al.
Publicado: (2022) -
Editorial: How to improve neuroscience education for the public and for a multi-professional audience in different parts of the globe
por: Arévalo, Analía, et al.
Publicado: (2022) -
What Does the General Public Know (or Not) About Neuroscience? Effects of Age, Region and Profession in Brazil
por: Arévalo, Analía, et al.
Publicado: (2022) -
T cell stimulation by dendritic cell-tumor cell hybrids is enhanced in the presence of free dendritic cells
por: Pinho, Mariana P, et al.
Publicado: (2013) -
Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy
por: Patente, Thiago A., et al.
Publicado: (2019)